Inhibition of interferon induction and action by the nairovirus nairobi sheep disease virus/Ganjam virus

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Holzer, Barbara ^a   Bakshi, Siddharth ^a,b   Bridgen, Anne ^b,c   Baron, Michael D ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c Croft Dhu   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INTERFERON; RNA POLYMERASE; UBIQUITIN; VIRUS PROTEIN; DNA DIRECTED RNA POLYMERASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NAIROBI SHEEP DISEASE VIRUS; NONHUMAN; POINT MUTATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS CELL INTERACTION; VIRUS IMMUNITY; ANIMAL; CELL STRAIN HEK293; CERCOPITHECUS; CHEMISTRY; GENETIC TRANSCRIPTION; GENETICS; GOAT; INNATE IMMUNITY; METABOLISM; PHOSPHORYLATION; PLASMID; PROMOTER REGION; PROTEIN TERTIARY STRUCTURE; REPORTER GENE; SHEEP; VERO CELL;

ANIMALS; CERCOPITHECUS AETHIOPS; DNA-DIRECTED RNA POLYMERASES; GENES, REPORTER; GOATS; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON-BETA; INTERFERON-GAMMA; INTERFERONS; NAIROBI SHEEP DISEASE VIRUS; PHOSPHORYLATION; PLASMIDS; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; SHEEP; TRANSCRIPTION, GENETIC; UBIQUITIN; VERO CELLS;

EID: 82655179958     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028594     Document Type: Article

References (64)

1. Montgomery E, (1917) On a tick-borne gastro-enteritis of sheep and goats occuring in British East Africa. J Comp Pathol 30: 28-57.
2. Marczinke BI, Nichol ST, (2002) Nairobi sheep disease virus, an important tick-borne pathogen of sheep and goats in Africa, is also present in Asia. Virology 303: 146-151.
3. Daubney R, Hudson JR, (1931) Nairobi Sheep Disease. Parasitology 23: 507-524.
4. Daubney R, Hudson JR, (1934) Nairobi Sheep Disease; natural and experimental transmission by ticks other than Rhipicephalus appendiculatus. Parasitology 26: 496-509.
5. Dandawate CN, Shah KV, (1969) Ganjam virus: a new arbovirus isolated from ticks Haemaphysalis intermedia Warburton and Nuttall, 1909 in Orissa, India. Indian J Med Res 57: 799-804.
6. Davies FG, (1978) Nairobi sheep disease in Kenya. The isolation of virus from sheep and goats, ticks and possible maintenance hosts. J Hyg (Lond) 81: 259-265.
7. Davies FG, (1978) A survey of Nairobi sheep disease antibody in sheep and goats, wild ruminants and rodents within Kenya. J Hyg (Lond) 81: 251-258.
8. Rao CV, Dandawate CN, Rodrigues JJ, Rao GL, Mandke VB, et al. (1981) Laboratory infections with Ganjam virus. Indian J Med Res 74: 319-324.
9. Dandawate CN, Work TH, Webb JK, Shah KV, (1969) Isolation of Ganjam virus from a human case of febrile illness: a report of a laboratory infection and serological survey of human sera from three different states of India. Indian J Med Res 57: 975-982.
10. Schmaljohn CS, Nichol ST, (2007) Bunyaviridae. In: Knipe DM, Howley PM, editors. Fields Virology. 5 ed: Lippincott Williams & Wilkins pp. 1743-1779.
11. Frias-Staheli N, Medina RA, Bridgen A, (2011) Nairovirus molecular biology and interaction with host cells. In: Plyusnin A, Elliott RM, editors. Bunyaviridae: Molecular and Cellular Biology: Caister Academic Press.
12. Ergonul O, (2006) Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6: 203-214.
13. Randall RE, Goodbourn S, (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1-47.
14. Ank N, West H, Paludan SR, (2006) IFN-lambda: novel antiviral cytokines. J Interferon Cytokine Res 26: 373-379.
15. Onoguchi K, Yoneyama M, Takemura A, Akira S, Taniguchi T, et al. (2007) Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem 282: 7576-7581.
16. Uze G, Monneron D, (2007) IL-28 and IL-29: newcomers to the interferon family. Biochimie 89: 729-734.
17. Der SD, Zhou A, Williams BR, Silverman RH, (1998) Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 95: 15623-15628.
18. Platanias LC, (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nature Rev Immunol 5: 375-386.
19. Andersson I, Bladh L, Mousavi-Jazi M, Magnusson KE, Lundkvist A, et al. (2004) Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J Virol 78: 4323-4329.
20. Bridgen A, Dalrymple DA, Weber F, Elliott RM, (2004) Inhibition of Dugbe nairovirus replication by human MxA protein. Virus Res 99: 47-50.
21. Andersson I, Karlberg H, Mousavi-Jazi M, Martinez-Sobrido L, Weber F, et al. (2008) Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response. J Med Virol 80: 1397-1404.
22. Habjan M, Andersson I, Klingstrom J, Schumann M, Martin A, et al. (2008) Processing of genome 5′ termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 3: e2032.
23. Honig JE, Osborne JC, Nichol ST, (2004) Crimean-Congo hemorrhagic fever virus genome L RNA segment and encoded protein. Virology 321: 29-35.
24. Frias-Staheli N, Giannakopoulos NV, Kikkert M, Taylor SL, Bridgen A, et al. (2007) Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2: 404-416.
25. Skaug B, Chen ZJ, (2010) Emerging role of ISG15 in antiviral immunity. Cell 143: 187-190.
26. Viswanathan K, Fruh K, DeFilippis V, (2010) Viral hijacking of the host ubiquitin system to evade interferon responses. Curr Opin Microbiol 13: 517-523.
27. Kayagaki N, Phung Q, Chan S, Chaudhari R, Quan C, et al. (2007) DUBA: a deubiquitinase that regulates type I interferon production. Science 318: 1628-1632.
28. Li S, Zheng H, Mao AP, Zhong B, Li Y, et al. (2010) Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J Biol Chem 285: 4291-4297.
29. Clementz MA, Chen Z, Banach BS, Wang Y, Sun L, et al. (2010) Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J Virol 84: 4619-4629.
30. Sun Z, Chen Z, Lawson SR, Fang Y, (2010) The cysteine protease domain of porcine reproductive and respiratory syndrome virus nonstructural protein 2 possesses deubiquitinating and interferon antagonism functions. J Virol 84: 7832-7846.
31. Yuan W, Krug RM, (2001) Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 20: 362-371.
32. Randow F, Lehner PJ, (2009) Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol 11: 527-534.
33. Park MS, Garcia-Sastre A, Cros JF, Basler CF, Palese P, (2003) Newcastle disease virus V protein is a determinant of host range restriction. J Virol 77: 9522-9532.
34. Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, et al. (1988) Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A 85: 5259-5263.
35. Emeny JM, Morgan MJ, (1979) Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J Gen Virol 43: 247-252.
36. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR, (2006) Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 80: 5059-5064.
37. Strahle L, Garcin D, Kolakofsky D, (2006) Sendai virus defective-interfering genomes and the activation of interferon-beta. Virology 351: 101-111.
38. Chang KC, Goldspink G, Lida J, (1990) Studies in the in vivo expression of the influenza resistance gene Mx by in-situ hybridisation. Arch Virol 110: 151-164.
39. Versteeg GA, Hale BG, van Boheemen S, Wolff T, Lenschow DJ, et al. (2010) Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein. J Virol 84: 5423-5430.
40. Farrell PJ, Broeze RJ, Lengyel P, (1979) Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature 279: 523-525.
41. Harty RN, Pitha PM, Okumura A, (2009) Antiviral activity of innate immune protein ISG15. J Innate Immun 1: 397-404.
42. Lai C, Struckhoff JJ, Schneider J, Martinez-Sobrido L, Wolff T, et al. (2009) Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J Virol 83: 1147-1151.
43. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, et al. (2007) IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104: 1371-1376.
44. Akutsu M, Ye Y, Virdee S, Chin JW, Komander D, (2011) Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains. Proc Natl Acad Sci U S A 108: 2228-2233.
45. James TW, Frias-Staheli N, Bacik JP, Levingston Macleod JM, Khajehpour M, et al. (2011) Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease. Proc Natl Acad Sci U S A 108: 2222-2227.
46. Bhoj VG, Chen ZJ, (2009) Ubiquitylation in innate and adaptive immunity. Nature 458: 430-437.
47. Malynn BA, Ma A, (2010) Ubiquitin makes its mark on immune regulation. Immunity 33: 843-852.
48. Gack MU, Shin YC, Joo CH, Urano T, Liang C, et al. (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446: 916-920.
49. Arimoto K, Funami K, Saeki Y, Tanaka K, Okawa K, et al. (2010) Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proc Natl Acad Sci U S A 107: 15856-15861.
50. DiDonato J, Mercurio F, Rosette C, Wu-Li J, Suyang H, et al. (1996) Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol 16: 1295-1304.
51. Takeuchi T, Kobayashi T, Tamura S, Yokosawa H, (2006) Negative regulation of protein phosphatase 2Cbeta by ISG15 conjugation. FEBS Lett 580: 4521-4526.
52. Shi HX, Yang K, Liu X, Liu XY, Wei B, et al. (2010) Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol 30: 2424-2436.
53. Barretto N, Jukneliene D, Ratia K, Chen Z, Mesecar AD, et al. (2005) The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J Virol 79: 15189-15198.
54. Lindner HA, Fotouhi-Ardakani N, Lytvyn V, Lachance P, Sulea T, et al. (2005) The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J Virol 79: 15199-15208.
55. Courtois G, (2008) Tumor suppressor CYLD: negative regulation of NF-kappaB signaling and more. Cell Mol Life Sci 65: 1123-1132.
56. Heyninck K, Beyaert R, (2005) A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions. Trends Biochem Sci 30: 1-4.
57. Wilkinson KD, (2009) DUBs at a glance. J Cell Sci 122: 2325-2329.
58. Capodagli GC, McKercher MA, Baker EA, Masters EM, Brunzelle JS, et al. (2011) Structural analysis of a viral ovarian tumor domain protease from the crimean-congo hemorrhagic Fever virus in complex with covalently bonded ubiquitin. J Virol 85: 3621-3630.
59. Hu M, Gu L, Li M, Jeffrey PD, Gu W, et al. (2006) Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway. PLoS Biol 4: e27.
60. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM, (2005) Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 102: 10200-10205.
61. Malakhov MP, Kim KI, Malakhova OA, Jacobs BS, Borden EC, et al. (2003) High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J Biol Chem 278: 16608-16613.
62. Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch KP, (2005) ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 25: 6338-6345.
63. Boxer EL, Nanda SK, Baron MD, (2009) The rinderpest virus non-structural C protein blocks the induction of type 1 interferon. Virology 385: 134-142.
64. Nanda SK, Baron MD, (2006) Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins. J Virol 80: 7555-7568.